StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Vaxcyte, Inc.
NasdaqGS:PCVX
Sector
Industries
Location
Market Cap
USD 4.60 B
Share Price
USD 35.64
Avg Daily Volume
2,040,715
Change (1 day)
-1.57%
Change (1 year)
-56.34%
Change (YTD)
-56.46%
Vaxcyte, Inc. Shareholders' Equity for the year ending December 31, 2024: USD 3.31 B
Vaxcyte, Inc. Shareholders' Equity is USD 3.31 B for the year ending December 31, 2024, a 166.50% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
-
Vaxcyte, Inc. Shareholders' Equity for the year ending December 31, 2023 was USD 1.24 B, a 30.08% change year over year.
-
Vaxcyte, Inc. Shareholders' Equity for the year ending December 31, 2022 was USD 953.61 M, a 235.76% change year over year.
-
Vaxcyte, Inc. Shareholders' Equity for the year ending December 31, 2021 was USD 284.02 M.
Competitors
Sanofi
USD 96.20
SAN.PA
-0.42
-0.44%
Moderna, Inc.
USD 30.97
MRNA
-0.29
-0.93%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.25
603392.SS
-0.11
-1.28%
Swedish Orphan Biovitrum AB (publ)
USD 27.92
SOBI.ST
-0.08
-0.29%
Chongqing Zhifei Biological Products Co., Ltd.
USD 2.83
300122.SZ
-0.00
-0.03%
Ionis Pharmaceuticals, Inc.
USD 41.55
IONS
-0.21
-0.50%
Rhythm Pharmaceuticals, Inc.
USD 88.63
RYTM
-0.57
-0.64%
Shanghai Junshi Biosciences Co., Ltd.
USD 3.20
1877.HK
-0.01
-0.43%
Hualan Biological Engineering Inc.
USD 2.27
002007.SZ
+0.01
0.33%
Ligand Pharmaceuticals Incorporated
USD 141.12
LGND
+2.02
1.45%
NewAmsterdam Pharma Company N.V.
USD 22.56
NAMS
+0.36
1.62%
Apellis Pharmaceuticals, Inc.
USD 19.28
APLS
-0.19
-0.98%
Apogee Therapeutics, Inc.
USD 39.11
APGE
-0.20
-0.51%
Bavarian Nordic A/S
USD 28.84
BAVA.CO
+0.17
0.61%
Immunocore Holdings plc
USD 36.93
IMCR
+0.62
1.71%
ARS Pharmaceuticals, Inc.
USD 17.85
SPRY
-0.07
-0.39%
Adaptive Biotechnologies Corporation
USD 10.31
ADPT
-0.08
-0.77%
AbbVie Inc.
USD 184.85
ABBV
-4.41
-2.33%
Novo Nordisk A/S
USD 64.18
NOVO-B.CO
-0.20
-0.32%
Roche Holding AG
USD 338.18
RO.SW
-2.81
-0.82%
Key Data
| Date | Shareholders' Equity | Cash and Short-Term Investments | Receivables | Inventory |
|---|
Competitors
Sanofi
USD 96.20
SAN.PA
-0.42
-0.44%
Moderna, Inc.
USD 30.97
MRNA
-0.29
-0.93%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 8.25
603392.SS
-0.11
-1.28%
Swedish Orphan Biovitrum AB (publ)
USD 27.92
SOBI.ST
-0.08
-0.29%
Chongqing Zhifei Biological Products Co., Ltd.
USD 2.83
300122.SZ
-0.00
-0.03%
Ionis Pharmaceuticals, Inc.
USD 41.55
IONS
-0.21
-0.50%
Rhythm Pharmaceuticals, Inc.
USD 88.63
RYTM
-0.57
-0.64%
Shanghai Junshi Biosciences Co., Ltd.
USD 3.20
1877.HK
-0.01
-0.43%
Hualan Biological Engineering Inc.
USD 2.27
002007.SZ
+0.01
0.33%
Ligand Pharmaceuticals Incorporated
USD 141.12
LGND
+2.02
1.45%
NewAmsterdam Pharma Company N.V.
USD 22.56
NAMS
+0.36
1.62%
Apellis Pharmaceuticals, Inc.
USD 19.28
APLS
-0.19
-0.98%
Apogee Therapeutics, Inc.
USD 39.11
APGE
-0.20
-0.51%
Bavarian Nordic A/S
USD 28.84
BAVA.CO
+0.17
0.61%
Immunocore Holdings plc
USD 36.93
IMCR
+0.62
1.71%
ARS Pharmaceuticals, Inc.
USD 17.85
SPRY
-0.07
-0.39%
Adaptive Biotechnologies Corporation
USD 10.31
ADPT
-0.08
-0.77%
AbbVie Inc.
USD 184.85
ABBV
-4.41
-2.33%
Novo Nordisk A/S
USD 64.18
NOVO-B.CO
-0.20
-0.32%
Roche Holding AG
USD 338.18
RO.SW
-2.81
-0.82%